Multisite Trial Early Data Suggests Remdesivir is Effective (UW Medicine Newsroom, Interview with Helen Chu)

Remdesivir, a non-specific antiviral drug that was originally tested against Ebola, has been shown to be effective against the new coronavirus in a preliminary data analysis, as reported by the National Institutes of Health. The UW School of Medicine was one of the sites in the National Institutes of Health trial. Dr.

The Conversation: Social Media Helps Officials Spot Public Health Threats -- But Only for the Rich?

By Elaine Nsoesie

Think of the last time you had food poisoning. Did you tweet about it? Did you Google your symptoms? Or did you write an angry review on Yelp?

Every day, people use the internet to seek and share health information. This opens up exciting new ways for scientists to study the health of a population, an approach known as digital epidemiology.

Devex: The Future of Health Financing: Investing in Data

By Annie Haakenstad and Joseph Dieleman 

After more than a decade of immense growth, development assistance for health has flat lined. Development assistance for health (DAH) fueled a scale up of antiretrovirals, insecticide-treated bed nets, vaccinations and a host of important global health interventions. Over the same period, the spread of a number of infectious diseases was reversed, reducing premature death and disability across the developing world. The plateau in international funding may threaten to slow progress or even roll back these gains.